Neutrophil elastase, proteinase 3 and cathepsin G: Physicochemical properties, activity and physiopathological functions

Biochimie

Volumn 90, Issue 2, 2008, Pages 227-242

  Korkmaz, Brice ^a   Moreau, Thierry ^a   Gauthier, Francis ^a  

^a UNIVERSITÉ DE TOURS   (France)

Author keywords

Human diseases; Inflammation; Neutrophil; Serine protease

Indexed keywords

CATHEPSIN G; CELL SURFACE RECEPTOR; CHEMOKINE; CYTOKINE; LEUKOCYTE ELASTASE; MYELOBLASTIN;

ARTICLE; CATALYSIS; CELL SURFACE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; EXTRACELLULAR MATRIX; GENE CONTROL; GENE EXPRESSION; GENE STRUCTURE; HUMAN; LEUKOCYTE ACTIVATION; NEUTROPHIL; NONHUMAN; PATHOGENICITY; PATHOPHYSIOLOGY; PHYSICAL CHEMISTRY; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; BINDING SITES; CATHEPSINS; HUMANS; INFLAMMATION; LEUKOCYTE ELASTASE; MOLECULAR SEQUENCE DATA; MYELOBLASTIN; SERINE ENDOPEPTIDASES; SUBSTRATE SPECIFICITY;

BACTERIA (MICROORGANISMS);

EID: 38849143983     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2007.10.009     Document Type: Article

References (213)

1. Schechter I., and Berger A. On the size of the active site in proteases. I. Papain. Biochem. Biophys. Res. Commun. 27 (1967) 157-162
2. Janoff A., and Scherer J. Mediators of inflammation in leukocyte lysosomes. IX. Elastinolytic activity in granules of human polymorphonuclear leukocytes. J. Exp. Med. 128 (1968) 1137-1155
3. Kao R.C., Wehner N.G., Skubitz K.M., Gray B.H., and Hoidal J.R. Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters. J. Clin. Invest. 82 (1988) 1963-1973
4. Baggiolini M., Schnyder J., Bretz U., Dewald B., and Ruch W. Cellular mechanisms of proteinase release from inflammatory cells and the degradation of extracellular proteins. Ciba Found. Symp. (1979) 105-121
5. Virca G.D., Metz G., and Schnebli H.P. Similarities between human and rat leukocyte elastase and cathepsin G. Eur. J. Biochem. 144 (1984) 1-9
6. Bank U., and Ansorge S. More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J. Leukoc. Biol. 69 (2001) 197-206
7. Taggart C.C., Greene C.M., Carroll T.P., O'Neill S.J., and McElvaney N.G. Elastolytic proteases: inflammation resolution and dysregulation in chronic infective lung disease. Am. J. Respir. Crit. Care Med. 171 (2005) 1070-1076
8. Wiedow O., and Meyer-Hoffert U. Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J. Intern. Med. 257 (2005) 319-328
9. Reid P.T., and Sallenave J.M. Neutrophil-derived elastases and their inhibitors: potential role in the pathogenesis of lung disease. Curr. Opin. Invest. Drugs 2 (2001) 59-67
10. Salvesen G., and Enghild J.J. Zymogen activation specificity and genomic structures of human neutrophil elastase and cathepsin G reveal a new branch of the chymotrypsinogen superfamily of serine proteinases. Biomed. Biochim. Acta 50 (1991) 665-671
11. Zimmer M., Medcalf R.L., Fink T.M., Mattmann C., Lichter P., and Jenne D.E. Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 8215-8219
12. Takahashi H., Nukiwa T., Yoshimura K., Quick C.D., States D.J., Holmes M.D., Whang-Peng J., Knutsen T., and Crystal R.G. Structure of the human neutrophil elastase gene. J. Biol. Chem. 263 (1988) 14739-14747
13. Wong E.T., Jenne D.E., Zimmer M., Porter S.D., and Gilks C.B. Changes in chromatin organization at the neutrophil elastase locus associated with myeloid cell differentiation. Blood 94 (1999) 3730-3736
14. Li F.Q., Person R.E., Takemaru K., Williams K., Meade-White K., Ozsahin A.H., Gungor T., Moon R.T., and Horwitz M. Lymphoid enhancer factor-1 links two hereditary leukemia syndromes through core-binding factor alpha regulation of ELA2. J. Biol. Chem. 279 (2004) 2873-2884
15. Lausen J., Liu S., Fliegauf M., Lubbert M., and Werner M.H. ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO. Oncogene 25 (2006) 1349-1357
16. Horwitz M., Benson K.F., Person R.E., Aprikyan A.G., and Dale D.C. Mutations in ELA2, encoding neutrophil elastase, define a 21-day biological clock in cyclic haematopoiesis. Nat. Genet. 23 (1999) 433-436
17. Horwitz M.S., Duan Z., Korkmaz B., Lee H.H., Mealiffe M.E., and Salipante S.J. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood 109 (2007) 1817-1824
18. Horwitz M., Benson K.F., Duan Z., Li F.Q., and Person R.E. Hereditary neutropenia: dogs explain human neutrophil elastase mutations. Trends Mol. Med. 10 (2004) 163-170
19. Campbell E.J., Silverman E.K., and Campbell M.A. Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity. J. Immunol. 143 (1989) 2961-2968
20. Senior R.M., Campbell E.J., Landis J.A., Cox F.R., Kuhn C., and Koren H.S. Elastase of U-937 monocytelike cells. Comparisons with elastases derived from human monocytes and neutrophils and murine macrophage-like cells. J. Clin. Invest. 69 (1982) 384-393
21. Liou T.G., and Campbell E.J. Nonisotropic enzyme-inhibitor interactions: a novel nonoxidative mechanism for quantum proteolysis by human neutrophils. Biochemistry 34 (1995) 16171-16177
22. Owen C.A., and Campbell E.J. Neutrophil proteinases and matrix degradation. The cell biology of pericellular proteolysis. Semin. Cell Biol. 6 (1995) 367-376
23. Allen D.H., and Tracy P.B. Human coagulation factor V is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface. J. Biol. Chem. 270 (1995) 1408-1415
24. Lungarella G., Menegazzi R., Gardi C., Spessotto P., de Santi M.M., Bertoncin P., Patriarca P., Calzoni P., and Zabucchi G. Identification of elastase in human eosinophils: immunolocalization, isolation, and partial characterization. Arch. Biochem. Biophys. 292 (1992) 128-135
25. Sturrock A.B., Espinosa III R., Hoidal J.R., and Le Beau M.M. Localization of the gene encoding proteinase-3 (the Wegener's granulomatosis autoantigen) to human chromosome band 19p13.3. Cytogenet. Cell Genet. 64 (1993) 33-34
26. Hohn P.A., Popescu N.C., Hanson R.D., Salvesen G., and Ley T.J. Genomic organization and chromosomal localization of the human cathepsin G gene. J. Biol. Chem. 264 (1989) 13412-13419
27. Farley D., Travis J., and Salvesen G. The human neutrophil elastase gene. Analysis of the nucleotide sequence reveals three distinct classes of repetitive DNA. Biol. Chem. Hoppe Seyler 370 (1989) 737-744
28. Sturrock A.B., Franklin K.F., Rao G., Marshall B.C., Rebentisch M.B., Lemons R.S., and Hoidal J.R. Structure, chromosomal assignment, and expression of the gene for proteinase-3. The Wegener's granulomatosis autoantigen. J. Biol. Chem. 267 (1992) 21193-21199
29. Bories D., Raynal M.C., Solomon D.H., Darzynkiewicz Z., and Cayre Y.E. Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells. Cell 59 (1989) 959-968
30. Campanelli D., Detmers P.A., Nathan C.F., and Gabay J.E. Azurocidin and a homologous serine protease from neutrophils. Differential antimicrobial and proteolytic properties. J. Clin. Invest. 85 (1990) 904-915
31. Labbaye C., Musette P., and Cayre Y.E. Wegener autoantigen and myeloblastin are encoded by a single mRNA. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 9253-9256
32. Abrink M., Gobl A.E., Huang R., Nilsson K., and Hellman L. Human cell lines U-937, THP-1 and Mono Mac 6 represent relatively immature cells of the monocyte-macrophage cell lineage. Leukemia 8 (1994) 1579-1584
33. Cowland J.B., and Borregaard N. The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J. Leukoc. Biol. 66 (1999) 989-995
34. Sturrock A., Franklin K.F., and Hoidal J.R. Human proteinase-3 expression is regulated by PU.1 in conjunction with a cytidine-rich element. J. Biol. Chem. 271 (1996) 32392-32402
35. Csernok E., Ludemann J., Gross W.L., and Bainton D.F. Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis. Am. J. Pathol. 137 (1990) 1113-1120
36. Csernok E., Ernst M., Schmitt W., Bainton D.F., and Gross W.L. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin. Exp. Immunol. 95 (1994) 244-250
37. Schreiber A., Busjahn A., Luft F.C., and Kettritz R. Membrane expression of proteinase 3 is genetically determined. J. Am. Soc. Nephrol. 14 (2003) 68-75
38. Braun M.G., Csernok E., Gross W.L., and Muller-Hermelink H.K. Proteinase 3, the target antigen of anticytoplasmic antibodies circulating in Wegener's granulomatosis. Immunolocalization in normal and pathologic tissues. Am. J. Pathol. 139 (1991) 831-838
39. Mayet W.J., Csernok E., Szymkowiak C., Gross W.L., and Meyer zum Buschenfelde K.H. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's granulomatosis. Blood 82 (1993) 1221-1229
40. Schwarting A., Hagen D., Odenthal M., Brockmann H., Dienes H.P., Wandel E., Rumpelt H.J., Zum Buschenfelde K.H., Galle P.R., and Mayet W. Proteinase-3 mRNA expressed by glomerular epithelial cells correlates with crescent formation in Wegener's granulomatosis. Kidney Int. 57 (2000) 2412-2422
41. Brockmann H., Schwarting A., Kriegsmann J., Petrow P., Gaumann A., Muller K.M., Galle P.R., and Mayet W. Proteinase-3 as the major autoantigen of c-ANCA is strongly expressed in lung tissue of patients with Wegener's granulomatosis. Arthritis Res. 4 (2002) 220-225
42. King W.J., Adu D., Daha M.R., Brooks C.J., Radford D.J., Pall A.A., and Savage C.O. Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3. Clin. Exp. Immunol. 102 (1995) 98-105
43. Pendergraft W.F., Alcorta D.A., Segelmark M., Yang J.J., Tuttle R., Jennette J.C., Falk R.J., and Preston G.A. ANCA antigens, proteinase 3 and myeloperoxidase, are not expressed in endothelial cells. Kidney Int. 57 (2000) 1981-1990
44. Caughey G.H., Schaumberg T.H., Zerweck E.H., Butterfield J.H., Hanson R.D., Silverman G.A., and Ley T.J. The human mast cell chymase gene (CMA1): mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression. Genomics 15 (1993) 614-620
45. Herrmann S.M., Funke-Kaiser H., Schmidt-Petersen K., Nicaud V., Gautier-Bertrand M., Evans A., Kee F., Arveiler D., Morrison C., Orzechowski H.D., Elbaz A., Amarenco P., Cambien F., and Paul M. Characterization of polymorphic structure of cathepsin G gene: role in cardiovascular and cerebrovascular diseases. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1538-1543
46. Shapiro S.D., Campbell E.J., Senior R.M., and Welgus H.G. Proteinases secreted by human mononuclear phagocytes. J. Rheumatol. Suppl. 27 (1991) 95-98
47. Sinha S., Watorek W., Karr S., Giles J., Bode W., and Travis J. Primary structure of human neutrophil elastase. Proc. Natl. Acad. Sci. U.S.A. 84 (1987) 2228-2232
48. Bode W., Wei A.Z., Huber R., Meyer E., Travis J., and Neumann S. X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBO J. 5 (1986) 2453-2458
49. Farley D., Salvesen G., and Travis J. Molecular cloning of human neutrophil elastase. Biol. Chem. Hoppe Seyler 369 Suppl (1988) 3-7
50. Skold S., Zeberg L., Gullberg U., and Olofsson T. Functional dissociation between proforms and mature forms of proteinase 3, azurocidin, and granzyme B in regulation of granulopoiesis. Exp. Hematol. 30 (2002) 689-696
51. Jenne D.E., and Kuhl A. Production and applications of recombinant proteinase 3, Wegener's autoantigen: problems and perspectives. Clin. Nephrol. 66 (2006) 153-159
52. Gullberg U., Andersson E., Garwicz D., Lindmark A., and Olsson I. Biosynthesis, processing and sorting of neutrophil proteins: insight into neutrophil granule development. Eur. J. Haematol. 58 (1997) 137-153
53. Gullberg U., Lindmark A., Lindgren G., Persson A.M., Nilsson E., and Olsson I. Carboxyl-terminal prodomain-deleted human leukocyte elastase and cathepsin G are efficiently targeted to granules and enzymatically activated in the rat basophilic/mast cell line RBL. J. Biol. Chem. 270 (1995) 12912-12918
54. Twumasi D.Y., and Liener I.E. Proteases from purulent sputum. Purification and properties of the elastase and chymotrypsin-like enzymes. J. Biol. Chem. 252 (1977) 1917-1926
55. Watorek W., van Halbeek H., and Travis J. The isoforms of human neutrophil elastase and cathepsin G differ in their carbohydrate side chain structures. Biol. Chem. Hoppe Seyler 374 (1993) 385-393
56. Green B.G., Weston H., Ashe B.M., Doherty J., Finke P., Hagmann W., Lark M., Mao J., Maycock A., Moore V., et al. PMN elastases: a comparison of the specificity of human isozymes and the enzyme from other species toward substrates and inhibitors. Arch. Biochem. Biophys. 286 (1991) 284-292
57. Rao N.V., Rao G.V., Marshall B.C., and Hoidal J.R. Biosynthesis and processing of proteinase 3 in U937 cells. Processing pathways are distinct from those of cathepsin G. J. Biol. Chem. 271 (1996) 2972-2978
58. Garwicz D., Lindmark A., Hellmark T., Gladh M., Jogi J., and Gullberg U. Characterization of the processing and granular targeting of human proteinase 3 after transfection to the rat RBL or the murine 32D leukemic cell lines. J. Leukoc. Biol. 61 (1997) 113-123
59. Capizzi S.A., Viss M.A., Hummel A.M., Fass D.N., and Specks U. Effects of carboxy-terminal modifications of proteinase 3 (PR3) on the recognition by PR3-ANCA. Kidney Int. 63 (2003) 756-760
60. Witko-Sarsat V., Cramer E.M., Hieblot C., Guichard J., Nusbaum P., Lopez S., Lesavre P., and Halbwachs-Mecarelli L. Presence of proteinase 3 in secretory vesicles: evidence of a novel, highly mobilizable intracellular pool distinct from azurophil granules. Blood 94 (1999) 2487-2496
61. Baici A., Szedlacsek S.E., Fruh H., and Michel B.A. pH-dependent hysteretic behaviour of human myeloblastin (leucocyte proteinase 3). Biochem. J. 317 Pt 3 (1996) 901-905
62. Korkmaz B., Hajjar E., Kalupov T., Reuter N., Brillard-Bourdet M., Moreau T., Juliano L., and Gauthier F. Influence of charge distribution at the active site surface on the substrate specificity of human neutrophil protease 3 and elastase. A kinetic and molecular modeling analysis. J. Biol. Chem. 282 (2007) 1989-1997
63. Niles J.L., McCluskey R.T., Ahmad M.F., and Arnaout M.A. Wegener's granulomatosis autoantigen is a novel neutrophil serine proteinase. Blood 74 (1989) 1888-1893
64. Goldschmeding R., van der Schoot C.E., ten Bokkel Huinink D., Hack C.E., van den Ende M.E., Kallenberg C.G., and von dem Borne A.E. Wegener's granulomatosis autoantibodies identify a novel diisopropylfluorophosphate-binding protein in the lysosomes of normal human neutrophils. J. Clin. Invest. 84 (1989) 1577-1587
65. Heegaard N.H., Jakobsen D.R., and Klattschou D. Purification of Wegener's granulomatosis autoantigen, proteinase 3, from neutrophils by Triton X-114 extraction of azurophilic granules. Anal. Biochem. 253 (1997) 259-262
66. Specks U., Fass D.N., Finkielman J.D., Hummel A.M., Viss M.A., Litwiller R.D., and McDonald C.J. Functional significance of Asn-linked glycosylation of proteinase 3 for enzymatic activity, processing, targeting, and recognition by anti-neutrophil cytoplasmic antibodies. J. Biochem. (Tokyo) 141 (2007) 101-112
67. Garwicz D., Lennartsson A., Jacobsen S.E., Gullberg U., and Lindmark A. Biosynthetic profiles of neutrophil serine proteases in a human bone marrow-derived cellular myeloid differentiation model. Haematologica 90 (2005) 38-44
68. Skold S., Rosberg B., Gullberg U., and Olofsson T. A secreted proform of neutrophil proteinase 3 regulates the proliferation of granulopoietic progenitor cells. Blood 93 (1999) 849-856
69. Salvesen G., Farley D., Shuman J., Przybyla A., Reilly C., and Travis J. Molecular cloning of human cathepsin G: structural similarity to mast cell and cytotoxic T lymphocyte proteinases. Biochemistry 26 (1987) 2289-2293
70. McGuire M.J., Lipsky P.E., and Thiele D.L. Generation of active myeloid and lymphoid granule serine proteases requires processing by the granule thiol protease dipeptidyl peptidase I. J. Biol. Chem. 268 (1993) 2458-2467
71. Garwicz D., Lindmark A., Persson A.M., and Gullberg U. On the role of the proform-conformation for processing and intracellular sorting of human cathepsin G. Blood 92 (1998) 1415-1422
72. Lindmark A., Persson A.M., and Olsson I. Biosynthesis and processing of cathepsin G and neutrophil elastase in the leukemic myeloid cell line U-937. Blood 76 (1990) 2374-2380
73. Lindmark A., Gullberg U., and Olsson I. Processing and intracellular transport of cathepsin G and neutrophil elastase in the leukemic myeloid cell line U-937-modulation by brefeldin A, ammonium chloride, and monensin. J. Leukoc. Biol. 55 (1994) 50-57
74. Salvesen G., and Enghild J.J. An unusual specificity in the activation of neutrophil serine proteinase zymogens. Biochemistry 29 (1990) 5304-5308
75. Starkey P.M., and Barrett A.J. Neutral proteinases of human spleen. Purification and criteria for homogeneity of elastase and cathepsin G. Biochem. J. 155 (1976) 255-263
76. Navia M.A., McKeever B.M., Springer J.P., Lin T.Y., Williams H.R., Fluder E.M., Dorn C.P., and Hoogsteen K. Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-A resolution. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 7-11
77. Wei A.Z., Mayr I., and Bode W. The refined 2.3 A crystal structure of human leukocyte elastase in a complex with a valine chloromethyl ketone inhibitor. FEBS Lett. 234 (1988) 367-373
78. Fujinaga M., Chernaia M.M., Halenbeck R., Koths K., and James M.N. The crystal structure of PR3, a neutrophil serine proteinase antigen of Wegener's granulomatosis antibodies. J. Mol. Biol. 261 (1996) 267-278
79. Hof P., Mayr I., Huber R., Korzus E., Potempa J., Travis J., Powers J.C., and Bode W. The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities. EMBO J. 15 (1996) 5481-5491
80. Hedstrom L. Serine protease mechanism and specificity. Chem. Rev. 102 (2002) 4501-4523
81. Lestienne P., and Bieth J.G. Activation of human leukocyte elastase activity by excess substrate, hydrophobic solvents, and ionic strength. J. Biol. Chem. 255 (1980) 9289-9294
82. Blow A.M., and Barrett A.J. Action of human cathepsin G on the oxidized B chain of insulin. Biochem. J. 161 (1977) 17-19
83. Koehl C., Knight C.G., and Bieth J.G. Compared action of neutrophil proteinase 3 and elastase on model substrates. Favorable effect of S′-P′ interactions on proteinase 3 catalysts. J. Biol. Chem. 278 (2003) 12609-12612
84. Yasutake A., and Powers J.C. Reactivity of human leukocyte elastase and porcine pancreatic elastase toward peptide 4-nitroanilides containing model desmosine residues. Evidence that human leukocyte elastase is selective for cross-linked regions of elastin. Biochemistry 20 (1981) 3675-3679
85. Stein R.L., and Strimpler A.M. Catalysis by human leukocyte elastase. Aminolysis of acyl-enzymes by amino acid amides and peptides. Biochemistry 26 (1987) 2238-2242
86. Korkmaz B., Attucci S., Moreau T., Godat E., Juliano L., and Gauthier F. Design and use of highly specific substrates of neutrophil elastase and proteinase 3. Am. J. Respir. Cell Mol. Biol. 30 (2004) 801-807
87. Rao N.V., Wehner N.G., Marshall B.C., Gray W.R., Gray B.H., and Hoidal J.R. Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties. J. Biol. Chem. 266 (1991) 9540-9548
88. Korkmaz B., Attucci S., Hazouard E., Ferrandiere M., Jourdan M.L., Brillard-Bourdet M., Juliano L., and Gauthier F. Discriminating between the activities of human neutrophil elastase and proteinase 3 using serpin-derived fluorogenic substrates. J. Biol. Chem. 277 (2002) 39074-39081
89. McRae B., Nakajima K., Travis J., and Powers J.C. Studies on reactivity of human leukocyte elastase, cathepsin G, and porcine pancreatic elastase toward peptides including sequences related to the reactive site of alpha 1-protease inhibitor (alpha 1-antitrypsin). Biochemistry 19 (1980) 3973-3978
90. Hajjar E., Korkmaz B., Gauthier F., Brandsdal B.O., Witko-Sarsat V., and Reuter N. Inspection of the binding sites of proteinase 3 for the design of a highly specific substrate. J. Med. Chem. 49 (2006) 1248-1260
91. Tanaka T., Minematsu Y., Reilly C.F., Travis J., and Powers J.C. Human leukocyte cathepsin G. Subsite mapping with 4-nitroanilides, chemical modification, and effect of possible cofactors. Biochemistry 24 (1985) 2040-2047
92. Réhault S., Brillard-Bourdet M., Juliano M.A., Juliano L., Gauthier F., Moreau T., and New. Sensitive fluorogenic substrates for human cathepsin G based on the sequence of serpin-reactive site loops. J. Biol. Chem. 274 (1999) 13810-13817
93. Attucci S., Korkmaz B., Juliano L., Hazouard E., Girardin C., Brillard-Bourdet M., Rehault S., Anthonioz P., and Gauthier F. Measurement of free and membrane-bound cathepsin G in human neutrophils using new sensitive fluorogenic substrates. Biochem. J. 366 (2002) 965-970
94. Segal D.M. A kinetic investigation of the crystallographically deduced binding subsites of bovine chymotrypsin A. Biochemistry 11 (1972) 349-356
95. Thompson R.C., and Blout E.R. Elastase-catalyzed amide hydrolysis of tri- and tetrapeptide amides. Biochemistry 12 (1973) 66-71
96. Segal D.M., Powers J.C., Cohen G.H., Davies D.R., and Wilcox P.E. Substrate binding site in bovine chymotrypsin A-gamma. A crystallographic study using peptide chloromethyl ketones as site-specific inhibitors. Biochemistry 10 (1971) 3728-3738
97. Schick C., Kamachi Y., Bartuski A.J., Çataltepe S., Schechter N.M., Pemberton P.A., and Silverman G.A. Squamous cell carcinoma antigen 2 is a novel serpin that inhibits the chymotrypsin-like proteinases cathepsin G and mast cell chymase. J. Biol. Chem. 272 (1997) 1849-1855
98. Potempa J., Korzus E., and Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J. Biol. Chem. 269 (1994) 15957-15960
99. Silverman G.A., Bird P.I., Carrell R.W., Church F.C., Coughlin P.B., Gettins P.G., Irving J.A., Lomas D.A., Luke C.J., Moyer R.W., Pemberton P.A., Remold-O'Donnell E., Salvesen G.S., Travis J., and Whisstock J.C. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J. Biol. Chem. 276 (2001) 33293-33296
100. Travis J., and Salvesen G.S. Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52 (1983) 655-709
101. Johnson D., and Travis J. The oxidative inactivation of human alpha-1-proteinase inhibitor. Further evidence for methionine at the reactive center. J. Biol. Chem. 254 (1979) 4022-4026
102. Beatty K., Bieth J., and Travis J. Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin. J. Biol. Chem. 255 (1980) 3931-3934
103. Padrines M., Schneider-Pozzer M., and Bieth J.G. Inhibition of neutrophil elastase by alpha-1-proteinase inhibitor oxidized by activated neutrophils. Am. Rev. Respir. Dis. 139 (1989) 783-790
104. Taggart C., Cervantes-Laurean D., Kim G., McElvaney N.G., Wehr N., Moss J., and Levine R.L. Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity. J. Biol. Chem. 275 (2000) 27258-27265
105. Travis J., Bowen J., and Baugh R. Human alpha-1-antichymotrypsin: interaction with chymotrypsin-like proteinases. Biochemistry 17 (1978) 5651-5656
106. Remold-O'Donnell E., Chin J., and Alberts M. Sequence and molecular characterization of human monocyte/neutrophil elastase inhibitor. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 5635-5639
107. Dahlen J.R., Foster D.C., and Kisiel W. Human proteinase inhibitor 9 (PI9) is a potent inhibitor of subtilisin A. Biochem. Biophys. Res. Commun. 238 (1997) 329-333
108. Scott F.L., Hirst C.E., Sun J., Bird C.H., Bottomley S.P., and Bird P.I. The intracellular serpin proteinase inhibitor 6 is expressed in monocytes and granulocytes and is a potent inhibitor of the azurophilic granule protease, cathepsin G. Blood 93 (1999) 2089-2097
109. Wiedow O., Luademann J., and Utecht B. Elafin is a potent inhibitor of proteinase 3. Biochem. Biophys. Res. Commun. 174 (1991) 6-10
110. Zani M.L., Nobar S.M., Lacour S.A., Lemoine S., Boudier C., Bieth J.G., and Moreau T. Kinetics of the inhibition of neutrophil proteinases by recombinant elafin and pre-elafin (trappin-2) expressed in Pichia pastoris. Eur. J. Biochem. 271 (2004) 2370-2378
111. Renesto P., Balloy V., Kamimura T., Masuda K., Imaizumi A., and Chignard M. Inhibition by recombinant SLPI and half-SLPI (Asn55-Ala107) of elastase and cathepsin G activities: consequence for neutrophil-platelet cooperation. Br. J. Pharmacol. 108 (1993) 1100-1106
112. Nobar S.M., Zani M.L., Boudier C., Moreau T., and Bieth J.G. Oxidized elafin and trappin poorly inhibit the elastolytic activity of neutrophil elastase and proteinase 3. FEBS J. 272 (2005) 5883-5893
113. Duranton J., Belorgey D., Carrere J., Donato L., Moritz T., and Bieth J.G. Effect of DNase on the activity of neutrophil elastase, cathepsin G and proteinase 3 in the presence of DNA. FEBS Lett. 473 (2000) 154-156
114. Pham C.T. Neutrophil serine proteases: specific regulators of inflammation. Nat. Rev. Immunol. 6 (2006) 541-550
115. Pipoly D.J., and Crouch E.C. Degradation of native type IV procollagen by human neutrophil elastase. Implications for leukocyte-mediated degradation of basement membranes. Biochemistry 26 (1987) 5748-5754
116. Starkey P.M., and Barrett A.J. Human lysosomal elastase. Catalytic and immunological properties. Biochem. J. 155 (1976) 265-271
117. Taylor J.C., Crawford I.P., and Hugli T.E. Limited degradation of the third component (C3) of human complement by human leukocyte elastase (HLE): partial characterization of C3 fragments. Biochemistry 16 (1977) 3390-3396
118. Orr F.W., Varani J., Kreutzer D.L., Senior R.M., and Ward P.A. Digestion of the fifth component of complement by leukocyte enzymes. Sequential generation of chemotactic activities for leukocytes and for tumor cells. Am. J. Pathol. 94 (1979) 75-83
119. Turkington P.T. Degradation of human factor X by human polymorphonuclear leucocyte cathepsin G and elastase. Haemostasis 21 (1991) 111-116
120. Anderssen T., Halvorsen H., Bajaj S.P., and Osterud B. Human leukocyte elastase and cathepsin G inactivate factor VII by limited proteolysis. Thromb. Haemost. 70 (1993) 414-417
121. Shafer W.M., Pohl J., Onunka V.C., Bangalore N., and Travis J. Human lysosomal cathepsin G and granzyme B share a functionally conserved broad spectrum antibacterial peptide. J. Biol. Chem. 266 (1991) 112-116
122. Cole A.M., Shi J., Ceccarelli A., Kim Y.H., Park A., and Ganz T. Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds. Blood 97 (2001) 297-304
123. Belaaouaj A. Neutrophil elastase-mediated killing of bacteria: lessons from targeted mutagenesis. Microbes Infect. 4 (2002) 1259-1264
124. Miyasaki K.T., Qu X.D., Harwig S.S., Cho Y., and Lehrer R.I. Identification of CG-1, a natural peptide antibiotic derived from human neutrophil cathepsin G. Adv. Dent. Res. 9 (1995) 63-66
125. Shafer W.M., Katzif S., Bowers S., Fallon M., Hubalek M., Reed M.S., Veprek P., and Pohl J. Tailoring an antibacterial peptide of human lysosomal cathepsin G to enhance its broad-spectrum action against antibiotic-resistant bacterial pathogens. Curr. Pharm. Des. 8 (2002) 695-702
126. Tkalcevic J., Novelli M., Phylactides M., Iredale J.P., Segal A.W., and Roes J. Impaired immunity and enhanced resistance to endotoxin in the absence of neutrophil elastase and cathepsin G. Immunity 12 (2000) 201-210
127. Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D.S., Weinrauch Y., and Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 303 (2004) 1532-1535
128. Lopez-Boado Y.S., Wilson C.L., and Parks W.C. Regulation of matrilysin expression in airway epithelial cells by Pseudomonas aeruginosa flagellin. J. Biol. Chem. 276 (2001) 41417-41423
129. Sorensen O.E., Follin P., Johnsen A.H., Calafat J., Tjabringa G.S., Hiemstra P.S., and Borregaard N. Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3. Blood 97 (2001) 3951-3959
130. Sugawara S. Immune functions of proteinase 3. Crit. Rev. Immunol. 25 (2005) 343-360
131. Owen C.A., and Campbell E.J. The cell biology of leukocyte-mediated proteolysis. J. Leukoc. Biol. 65 (1999) 137-150
132. Korkmaz B., Attucci S., Jourdan M.L., Juliano L., and Gauthier F. Inhibition of neutrophil elastase by alpha1-protease inhibitor at the surface of human polymorphonuclear neutrophils. J. Immunol. 175 (2005) 3329-3338
133. Halbwachs-Mecarelli L., Bessou G., Lesavre P., Lopez S., and Witko-Sarsat V. Bimodal distribution of proteinase 3 (PR3) surface expression reflects a constitutive heterogeneity in the polymorphonuclear neutrophil pool. FEBS Lett. 374 (1995) 29-33
134. Bauer S., Abdgawad M., Gunnarsson L., Segelmark M., Tapper H., and Hellmark T. Proteinase 3 and CD177 are expressed on the plasma membrane of the same subset of neutrophils. J. Leukoc. Biol. 81 (2007) 458-464
135. Campbell E.J., and Owen C.A. The sulfate groups of chondroitin sulfate- and heparan sulfate-containing proteoglycans in neutrophil plasma membranes are novel binding sites for human leukocyte elastase and cathepsin G. J. Biol. Chem. 282 (2007) 14645-14654
136. Fridlich R., David A., and Aviram I. Membrane proteinase 3 and its interactions within microdomains of neutrophil membranes. J. Cell Biochem. 99 (2006) 117-125
137. von Vietinghoff S., Tunnemann G., Eulenberg C., Wellner M., Cristina Cardoso M., Luft F.C., and Kettritz R. NB1 mediates surface expression of the ANCA antigen proteinase 3 on human neutrophils. Blood 109 (2007) 4487-4493
138. Preston G.A., Zarella C.S., Pendergraft III W.F., Rudolph E.H., Yang J.J., Sekura S.B., Jennette J.C., and Falk R.J. Novel effects of neutrophil-derived proteinase 3 and elastase on the vascular endothelium involve in vivo cleavage of NF-kappaB and proapoptotic changes in JNK, ERK, and p38 MAPK signaling pathways. J. Am. Soc. Nephrol. 13 (2002) 2840-2849
139. Dublet B., Ruello A., Pederzoli M., Hajjar E., Courbebaisse M., Canteloup S., Reuter N., and Witko-Sarsat V. Cleavage of p21/WAF1/CIP1 by Proteinase 3 modulates differentiation of a monocytic cell line. Molecular analysis of the cleavage site. J. Biol. Chem. 280 (2005) 30242-30253
140. Robache-Gallea S., Morand V., Bruneau J.M., Schoot B., Tagat E., Realo E., Chouaib S., and Roman-Roman S. In vitro processing of human tumor necrosis factor-alpha. J. Biol. Chem. 270 (1995) 23688-23692
141. Rogalski C., Meyer-Hoffert U., Proksch E., and Wiedow O. Human leukocyte elastase induces keratinocyte proliferation in vitro and in vivo. J. Invest. Dermatol. 118 (2002) 49-54
142. Devaney J.M., Greene C.M., Taggart C.C., Carroll T.P., O'Neill S.J., and McElvaney N.G. Neutrophil elastase up-regulates interleukin-8 via toll-like receptor 4. FEBS Lett. 544 (2003) 129-132
143. Sambrano G.R., Huang W., Faruqi T., Mahrus S., Craik C., and Coughlin S.R. Cathepsin G activates protease-activated receptor-4 in human platelets. J. Biol. Chem. 275 (2000) 6819-6823
144. Uehara A., Sugawara S., Muramoto K., and Takada H. Activation of human oral epithelial cells by neutrophil proteinase 3 through protease-activated receptor-2. J. Immunol. 169 (2002) 4594-4603
145. Geraghty P., Rogan M.P., Greene C.M., Boxio R.M., Poiriert T., O'Mahony M., Belaaouaj A., O'Neill S.J., Taggart C.C., and McElvaney N.G. Neutrophil elastase up-regulates cathepsin B and matrix metalloprotease-2 expression. J. Immunol. 178 (2007) 5871-5878
146. Lee W.L., and Downey G.P. Leukocyte elastase: physiological functions and role in acute lung injury. Am. J. Respir. Crit. Care Med. 164 (2001) 896-904
147. Kawabata K., Hagio T., and Matsuoka S. The role of neutrophil elastase in acute lung injury. Eur. J. Pharmacol. 451 (2002) 1-10
148. Moraes T.J., Chow C.W., and Downey G.P. Proteases and lung injury. Crit. Care Med. 31 (2003) S189-S194
149. Schrijver G., Schalkwijk J., Robben J.C., Assmann K.J., and Koene R.A. Antiglomerular basement membrane nephritis in beige mice. Deficiency of leukocytic neutral proteinases prevents the induction of albuminuria in the heterologous phase. J. Exp. Med. 169 (1989) 1435-1448
150. Liu Z., Shapiro S.D., Zhou X., Twining S.S., Senior R.M., Giudice G.J., Fairley J.A., and Diaz L.A. A critical role for neutrophil elastase in experimental bullous pemphigoid. J. Clin. Invest. 105 (2000) 113-123
151. Laurell C.B., and Eriksson S. The electrophoretic alpha 1-globulin pattern of serum in alpha 1-antitrypsin deficiency. Scand. J. Clin. Lab. Invest. 15 (1963) 132-140
152. Niehaus G.D., and Reddan W.G. Development of a canine model of experimental emphysema by intratracheal instillation of elastase. Chest 77 (1980) 276-278
153. Lee W.L., and Downey G.P. Neutrophil activation and acute lung injury. Curr. Opin. Crit. Care. 7 (2001) 1-7
154. Nathan C. Points of control in inflammation. Nature 420 (2002) 846-852
155. Hansen G., Schuster A., Zubrod C., and Wahn V. Alpha 1-proteinase inhibitor abrogates proteolytic and secretagogue activity of cystic fibrosis sputum. Respiration 62 (1995) 117-124
156. Witko-Sarsat V., Halbwachs-Mecarelli L., Schuster A., Nusbaum P., Ueki I., Canteloup S., Lenoir G., Descamps-Latscha B., and Nadel J.A. Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum. Am. J. Respir. Cell Mol. Biol. 20 (1999) 729-736
157. Campbell E.J., and Campbell M.A. Pericellular proteolysis by neutrophils in the presence of proteinase inhibitors: effects of substrate opsonization. J. Cell Biol. 106 (1988) 667-676
158. Campbell E.J., Campbell M.A., Boukedes S.S., and Owen C.A. Quantum proteolysis by neutrophils: implications for pulmonary emphysema in alpha 1-antitrypsin deficiency. J. Clin. Invest. 104 (1999) 337-344
159. Owen C.A., Campbell M.A., Sannes P.L., Boukedes S.S., and Campbell E.J. Cell surface-bound elastase and cathepsin G on human neutrophils: a novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteinases. J. Cell Biol. 131 (1995) 775-789
160. Campbell E.J., Senior R.M., and Welgus H.G. Extracellular matrix injury during lung inflammation. Chest 92 (1987) 161-167
161. Chan S.C., Shum D.K., and Ip M.S. Sputum sol neutrophil elastase activity in bronchiectasis: differential modulation by syndecan-1. Am. J. Respir. Crit. Care Med. 168 (2003) 192-198
162. Attucci S., Gauthier A., Korkmaz B., Delepine P., Martino M.F., Saudubray F., Diot P., and Gauthier F. EPI-hNE4, a proteolysis-resistant inhibitor of human neutrophil elastase and potential anti-inflammatory drug for treating cystic fibrosis. J. Pharmacol. Exp. Ther. 318 (2006) 803-809
163. Jenne D.E., Tschopp J., Ludemann J., Utecht B., and Gross W.L. Wegener's autoantigen decoded. Nature 346 (1990) 520
164. Rarok A.A., Limburg P.C., and Kallenberg C.G. Neutrophil-activating potential of antineutrophil cytoplasm autoantibodies. J. Leukoc. Biol. 74 (2003) 3-15
165. Bosch X., Guilabert A., and Font J. Antineutrophil cytoplasmic antibodies. Lancet 368 (2006) 404-418
166. Esnault V.L., Testa A., Audrain M., Roge C., Hamidou M., Barrier J.H., Sesboue R., Martin J.P., and Lesavre P. Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int. 43 (1993) 1329-1332
167. Segelmark M., Elzouki A.N., Wieslander J., and Eriksson S. The PiZ gene of alpha 1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis. Kidney Int. 48 (1995) 844-850
168. Uehara A., Sugawara Y., Sasano T., Takada H., and Sugawara S. Proinflammatory cytokines induce proteinase 3 as membrane-bound and secretory forms in human oral epithelial cells and antibodies to proteinase 3 activate the cells through protease-activated receptor-2. J. Immunol. 173 (2004) 4179-4189
169. Pederzoli M., Kantari C., Gausson V., Moriceau S., and Witko-Sarsat V. Proteinase-3 induces procaspase-3 activation in the absence of apoptosis: potential role of this compartmentalized activation of membrane-associated procaspase-3 in neutrophils. J. Immunol. 174 (2005) 6381-6390
170. Witko-Sarsat V., Canteloup S., Durant S., Desdouets C., Chabernaud R., Lemarchand P., and Descamps-Latscha B. Cleavage of p21waf1 by proteinase-3, a myeloid-specific serine protease, potentiates cell proliferation. J. Biol. Chem. 277 (2002) 47338-47347
171. Pendergraft III W.F., Preston G.A., Shah R.R., Tropsha A., Carter Jr. C.W., Jennette J.C., and Falk R.J. Autoimmunity is triggered by cPR-3(105-201), a protein complementary to human autoantigen proteinase-3. Nat. Med. 10 (2004) 72-79
172. Dale D.C., Person R.E., Bolyard A.A., Aprikyan A.G., Bos C., Bonilla M.A., Boxer L.A., Kannourakis G., Zeidler C., Welte K., Benson K.F., and Horwitz M. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood 96 (2000) 2317-2322
173. Li F.Q., and Horwitz M. Characterization of mutant neutrophil elastase in severe congenital neutropenia. J. Biol. Chem. 276 (2001) 14230-14241
174. Aprikyan A.A., and Dale D.C. Mutations in the neutrophil elastase gene in cyclic and congenital neutropenia. Curr. Opin. Immunol. 13 (2001) 535-538
175. Ancliff P.J., Gale R.E., Liesner R., Hann I.M., and Linch D.C. Mutations in the ELA2 gene encoding neutrophil elastase are present in most patients with sporadic severe congenital neutropenia but only in some patients with the familial form of the disease. Blood 98 (2001) 2645-2650
176. Kollner I., Sodeik B., Schreek S., Heyn H., von Neuhoff N., Germeshausen M., Zeidler C., Kruger M., Schlegelberger B., Welte K., and Beger C. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response. Blood 108 (2006) 493-500
177. Lane A.A., and Ley T.J. Neutrophil elastase cleaves PML-RARalpha and is important for the development of acute promyelocytic leukemia in mice. Cell 115 (2003) 305-318
178. Lane A.A., and Ley T.J. Neutrophil elastase is important for PML-retinoic acid receptor alpha activities in early myeloid cells. Mol. Cell. Biol. 25 (2005) 23-33
179. Hart T.C., Hart P.S., Bowden D.W., Michalec M.D., Callison S.A., Walker S.J., Zhang Y., and Firatli E. Mutations of the cathepsin C gene are responsible for Papillon-Lefevre syndrome. J. Med. Genet. 36 (1999) 881-887
180. Toomes C., James J., Wood A.J., Wu C.L., McCormick D., Lench N., Hewitt C., Moynihan L., Roberts E., Woods C.G., Markham A., Wong M., Widmer R., Ghaffar K.A., Pemberton M., Hussein I.R., Temtamy S.A., Davies R., Read A.P., Sloan P., Dixon M.J., and Thakker N.S. Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat. Genet. 23 (1999) 421-424
181. Tremblay G.M., Janelle M.F., and Bourbonnais Y. Anti-inflammatory activity of neutrophil elastase inhibitors. Curr. Opin. Invest. Drugs 4 (2003) 556-565
182. Lomas D.A., Stone S.R., Llewellyn-Jones C., Keogan M.T., Wang Z.M., Rubin H., Carrell R.W., and Stockley R.A. The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin. J. Biol. Chem. 270 (1995) 23437-23443
183. Duranton J., Adam C., and Bieth J.G. Kinetic mechanism of the inhibition of cathepsin G by alpha 1-antichymotrypsin and alpha 1-proteinase inhibitor. Biochemistry 37 (1998) 11239-11245
184. Cooley J., Takayama T.K., Shapiro S.D., Schechter N.M., and Remold-O'Donnell E. The serpin MNEI inhibits elastase-like and chymotrypsin-like serine proteases through efficient reactions at two active sites. Biochemistry 40 (2001) 15762-15770
185. Gauthier F., Fryksmark U., Ohlsson K., and Bieth J.G. Kinetics of the inhibition of leukocyte elastase by the bronchial inhibitor. Biochim. Biophys. Acta 700 (1982) 178-183
186. Fath M.A., Wu X., Hileman R.E., Linhardt R.J., Kashem M.A., Nelson R.M., Wright C.D., and Abraham W.M. Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma. J. Biol. Chem. 273 (1998) 13563-13569
187. Ying Q.L., and Simon S.R. Kinetics of the inhibition of human leukocyte elastase by elafin, a 6-kilodalton elastase-specific inhibitor from human skin. Biochemistry 32 (1993) 1866-1874
188. Ying Q.L., and Simon S.R. Kinetics of the inhibition of proteinase 3 by elafin. Am. J. Respir. Cell Mol. Biol. 24 (2001) 83-89
189. Dahlen J.R., Foster D.C., and Kisiel W. Inhibition of neutrophil elastase by recombinant human proteinase inhibitor 9. Biochim. Biophys. Acta 1451 (1999) 233-241
190. Rao N.V., Marshall B.C., Gray B.H., and Hoidal J.R. Interaction of secretory leukocyte protease inhibitor with proteinase-3. Am. J. Respir. Cell Mol. Biol. 8 (1993) 612-616
191. Sun J., Coughlin P., Salem H.H., and Bird P. Production and characterization of recombinant human proteinase inhibitor 6 expressed in Pichia pastoris. Biochim. Biophys. Acta 1252 (1995) 28-34
192. Gadher S.J., Eyre D.R., Duance V.C., Wotton S.F., Heck L.W., Schmid T.M., and Woolley D.E. Susceptibility of cartilage collagens type II, IX, X, and XI to human synovial collagenase and neutrophil elastase. Eur. J. Biochem. 175 (1988) 1-7
193. Kittelberger R., Neale T.J., Francky K.T., Greenhill N.S., and Gibson G.J. Cleavage of type VIII collagen by human neutrophil elastase. Biochim. Biophys. Acta 1139 (1992) 295-299
194. Heck L.W., Blackburn W.D., Irwin M.H., and Abrahamson D.R. Degradation of basement membrane laminin by human neutrophil elastase and cathepsin G. Am. J. Pathol. 136 (1990) 1267-1274
195. Janusz M.J., and Doherty N.S. Degradation of cartilage matrix proteoglycan by human neutrophils involves both elastase and cathepsin G. J. Immunol. 146 (1991) 3922-3928
196. Doring G., Frank F., Boudier C., Herbert S., Fleischer B., and Bellon G. Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis. J. Immunol. 154 (1995) 4842-4850
197. Hirche T.O., Crouch E.C., Espinola M., Brokelman T.J., Mecham R.P., DeSilva N., Cooley J., Remold-O'Donnell E., and Belaaouaj A. Neutrophil serine proteinases inactivate surfactant protein D by cleaving within a conserved subregion of the carbohydrate recognition domain. J. Biol. Chem. 279 (2004) 27688-27698
198. Renesto P., and Chignard M. Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: consequence for the neutrophil-mediated platelet activation. Blood 82 (1993) 139-144
199. Tschesche H., Knauper V., Kramer S., Michaelis J., Oberhoff R., and Reinke H. Latent collagenase and gelatinase from human neutrophils and their activation. Matrix Suppl. 1 (1992) 245-255
200. Rice A., and Banda M.J. Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix. Biochemistry 34 (1995) 9249-9256
201. Jordan R.E., Nelson R.M., Kilpatrick J., Newgren J.O., Esmon P.C., and Fournel M.A. Inactivation of human antithrombin by neutrophil elastase. Kinetics of the heparin-dependent reaction. J. Biol. Chem. 264 (1989) 10493-10500
202. Wu K., Urano T., Ihara H., Takada Y., Fujie M., Shikimori M., Hashimoto K., and Takada A. The cleavage and inactivation of plasminogen activator inhibitor type 1 by neutrophil elastase: the evaluation of its physiologic relevance in fibrinolysis. Blood 86 (1995) 1056-1061
203. Bedard M., McClure C.D., Schiller N.L., Francoeur C., Cantin A., and Denis M. Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis. Am. J. Respir. Cell Mol. Biol. 9 (1993) 455-462
204. Nadel J.A. Role of mast cell and neutrophil proteases in airway secretion. Am. Rev. Respir. Dis. 144 (1991) S48-S51
205. Gabay J.E., Scott R.W., Campanelli D., Griffith J., Wilde C., Marra M.N., Seeger M., and Nathan C.F. Antibiotic proteins of human polymorphonuclear leukocytes. Proc. Natl. Acad. Sci. U.S.A. 86 (1989) 5610-5614
206. Renesto P., Halbwachs-Mecarelli L., Nusbaum P., Lesavre P., and Chignard M. Proteinase 3. A neutrophil proteinase with activity on platelets. J. Immunol. 152 (1994) 4612-4617
207. Yang J.J., Preston G.A., Pendergraft W.F., Segelmark M., Heeringa P., Hogan S.L., Jennette J.C., and Falk R.J. Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants. Am. J. Pathol. 158 (2001) 581-592
208. Jennette J.C., Hoidal J.R., and Falk R.J. Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3. Blood 75 (1990) 2263-2264
209. Baggiolini M., Bretz U., Dewald B., and Feigenson M.E. The polymorphonuclear leukocyte. Agents Actions 8 (1978) 3-10
210. Mak P., Pohl J., Dubin A., Reed M.S., Bowers S.E., Fallon M.T., and Shafer W.M. The increased bactericidal activity of a fatty acid-modified synthetic antimicrobial peptide of human cathepsin G correlates with its enhanced capacity to interact with model membranes. Int J. Antimicrob. Agents 21 (2003) 13-19
211. Le-Barillec K., Pidard D., Balloy V., and Chignard M. Human neutrophil cathepsin G down-regulates LPS-mediated monocyte activation through CD14 proteolysis. J. Leukoc. Biol. 68 (2000) 209-215
212. Beaufort N., Leduc D., Rousselle J.C., Magdolen V., Luther T., Namane A., Chignard M., and Pidard D. Proteolytic regulation of the urokinase receptor/CD87 on monocytic cells by neutrophil elastase and cathepsin G. J. Immunol. 172 (2004) 540-549
213. Reilly C.F., Tewksbury D.A., Schechter N.M., and Travis J. Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J. Biol. Chem. 257 (1982) 8619-8622